echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > A class of anti-blood pressure drugs can alleviate the seriousness of neo-crown pneumonia.

    A class of anti-blood pressure drugs can alleviate the seriousness of neo-crown pneumonia.

    • Last Update: 2020-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A single-variable analysis of all these patients showed that factors such as old age (over 65 years of age), history of cardiovascular disease, diabetes and hypertension were associated with severe pneumonia requiring oxygen absorption;
    In addition, the team investigated new coronavirus infections with hypertension and found that patients who took the antihypertensive drug nephrogen-angiotensin system inhibitor, angiotensin-converting enzyme inhibitor (ACE inhibitor) or angiotensin-stressor antagonist (ARB) before contracting the new coronavirus had a lower incidence of consciousness disorders associated with the new coronavirus infection.
    results suggest that the nephrine-angiosin system inhibitors are expected to alleviate the severity of neo-coronavirus infections.
    (Source: Japan Science and Technology Revitalization Agency Editor-in-Chief: Chen Chao, Reporter of this newspaper in Japan)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.